jpad journal
IF 2023 : 8.5

AND option

OR option

Archives

Back to all journals

journal articles

VIEWPOINT: WHAT IS REASONABLE AND NECESSARY FOR PEOPLE LIVING WITH AD AFTER THE FDA APPROVES A TREATMENT?

R.S. Doody, S. Skerjanec

J Prev Alz Dis 2023;3(10):344-345



CITATION:
R.S. Doody ; S. Skerjanec ; ; (2023): Viewpoint: What Is Reasonable and Necessary for People Living with AD after the FDA Approves a Treatment?. The Journal of Prevention of Alzheimer’s Disease (JPAD). http://dx.doi.org/10.14283/jpad.2023.74

OPEN ACCESS

Download PDF (215.76 Ko)View HTML